Report · Health

A slim majority of Americans would consider a pneumococcal vaccine

Reading

In a Verasight survey of 1,000 U.S. adults conducted Nov. 19 to 22, 2024, 53% of Americans said they are at least somewhat likely to consider receiving a pneumococcal disease vaccine if eligible. Including 34% who said very likely, with another 20% who said somewhat likely.

About a quarter said they are unlikely to consider it (24%), with 15% who said very unlikely and 9% who said somewhat unlikely. Another 23% were neutral.

Topline

response scale

Topline scale

53% of Americans are at least somewhat likely to consider a pneumococcal vaccine if eligible.

How likely are you to consider receiving a Streptococcus Pneumoniae (Pneumococcal disease) vaccine if you are eligible?

  • Very likely 33.6%
  • Neutral 22.7%
  • Somewhat likely 19.9%
  • Very unlikely 14.8%
  • Somewhat unlikely 9.1%

2024 · base n 1,000 · +/- 3.4%

A

View source

Methodology

Full methodology
Mode
Verasight panel recruited via random address-based sampling, random person-to-person text messaging, and dynamic online targeting
Field dates
2024-11-19 → 2024-11-22
Base (unweighted)
1,000
Margin of error
+/- 3.4%
Module
A

Source

  • 01
    A slim majority of Americans would consider a pneumococcal vaccinereports.verasight.io/reports/verasight-apha-omnibus-survey-2024-122

Citation

Verasight APHA Omnibus Survey #2024-122, fielded November 19-22, 2024, N=1,000 United States adults, +/- 3.4%.

https://reports.verasight.io/reports/verasight-apha-omnibus-survey-2024-122#q-a-5

Verasight survey methodology

How Verasight conducts surveys.

This page describes the Verasight general survey contract, separate from how the Data Library packages it. Each wave's specific field dates, sample sizes, and module breakdown are listed in that wave's report.

Mode
Verasight panel recruited via random address-based sampling, random person-to-person text messaging, and dynamic online targeting.
Population
US adults age 18+.
Sample design
Surveys are run as omnibus or single-topic waves. Omnibus waves are split into modules with their own respondent set, typically around one thousand respondents per module.
Field window
Each wave specifies its own field dates. Most omnibus waves field across roughly two weeks.
Weighting
Per-module weighting to CPS targets including age, race and ethnicity, sex, income, education, region, and metropolitan status.
Partisanship benchmark
Pew Research Center's NPORS benchmarking surveys, three-year running average.
Vote benchmark
2024 presidential vote population benchmarks.
Margin of error
Typically about plus or minus 3.4 to 3.6 percent per module at standard module sizes. Question-level MoE is recomputed when a base shrinks materially below the module baseline.
Reporting
Every wave is published as a standalone report at verasight.io/reports with full instrument and methodology.
Transparency
AAPOR transparency standards.

Wave-specific methodology, full weighting variable lists, and verbatim instrument text live in each report at verasight.io/reports.